The American biotech presents very encouraging preliminary results concerning the phase III study of its candidate vaccine against the coronavirus. According to Moderna, the treatment would be almost 95% effective. Finally, the American biotech announces better conservation of its product.
Covid: Moderna announces vaccine even more effective than Pfizer's
